Gilyazova, I.R.,
Ivanova, E.A.,
Bermisheva, M.A.,
Loginova, M.V.,
Asadullina, D.D.,
Ishemgulov, R.R.,
Mustafin, A.T.,
Pavlov, V.N.,
Khusnutdinova, E.K. (2022) of PTEN, rs17878362 of TP53, and rs2699887 of PIK3CA with the risk of
prostate cancer development. As a
Dzhaubermezov, M.,
Ekomasova, N.,
Mustafin, R.,
Gabidullina, L.,
Galimova, Y.,
Nurgalieva, A.,
Valova, Y.,
Prokofyeva, D.,
Khusnutdinova, E. (2022) to the pathogenesis of some multifactorial traits and diseases, such as
cancer,
particularly
prostate cancerSufianova, Galina,
Sufianova, Galina,
Beylerli, Ozal,
Wu, Jianing,
Shumadalova, Alina,
Sufianov, Albert,
Chen, Xin,
Zhao, Shiguang (2022) of
cancer. The onset and progression of tumors may be related directly to oxidative stress, or inflammation
Beilerli, A.,
Gareev, I.,
Beylerli, O.,
Yang, G.,
V.N. Pavlov,
Aliev, G.,
Ahmad, A. (2022) further makes them suitable as
cancer biomarkers. Studies involving human tumors have verified differences
Despite many advances in diagnosis and therapy (surgery, radiation therapy, chemotherapy),
cancer